← back to search

Robert L. Johnston

Cambridge University Hospitals NHS Foundation Trust · GB
Area of research
Ophthalmology · Epidemiology
Research interest
Research focused on Macular degeneration and Vitrectomy, with related work in Pars plana, Ranibizumab, Visual acuity. Notable publications include 'Defining response to anti-VEGF therapies in neovascular AMD', 'United Kingdom National Ophthalmology Database Study of Vitreoretinal Surgery', and 'United Kingdom National Ophthalmology Database Study of Vitreoretinal Surgery: Report 2, Macular Hole'.
h-index
—
citations
1,108
works
8
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom
Advances in Therapy 2017cited by 50position: firstdoi
Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration
American Journal of Ophthalmology 2016cited by 114position: middledoi
Defining response to anti-VEGF therapies in neovascular AMD
Eye 2015cited by 342position: middledoi
The Royal College of Ophthalmologists’ National Ophthalmology Database Study of Vitreoretinal Surgery
JAMA Ophthalmology 2015cited by 62position: middledoi
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12
British Journal of Ophthalmology 2015cited by 59position: middledoi
United Kingdom National Ophthalmology Database Study of Vitreoretinal Surgery
Ophthalmology 2013cited by 179position: lastdoi
United Kingdom National Ophthalmology Database Study of Vitreoretinal Surgery: Report 1; Case mix, complications, and cataract
Eye 2013cited by 132position: lastdoi
United Kingdom National Ophthalmology Database Study of Vitreoretinal Surgery: Report 2, Macular Hole
Ophthalmology 2012cited by 170position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

J M Sparrow · University Hospitals Bristol NHS Foundation Trust4 papers (2012–2015)Paul H. J. Donachie · University of Leicester4 papers (2012–2015)Timothy L. Jackson · King's College London4 papers (2012–2015)Adnan Tufail · Moorfields Eye Hospital NHS Foundation Trust3 papers (2015–2016)Usha Chakravarthy · Queen's University Belfast2 papers (2015–2015)— · 1 papers (2015–2015)Paul Mitchell · The University of Sydney1 papers (2017–2017)— · 1 papers (2015–2015)Jonathan Gibson · University of Southampton1 papers (2015–2015)— · 1 papers (2016–2016)Mark C. Gillies · The University of Sydney1 papers (2016–2016)Pearse A. Keane · Moorfields Eye Hospital NHS Foundation Trust1 papers (2015–2015)— · 1 papers (2016–2016)Yit C. Yang · Case Western Reserve University1 papers (2015–2015)A Skelly · Novartis (Switzerland)1 papers (2017–2017)Winfried M. K. Amoaku · University of Nottingham1 papers (2015–2015)— · 1 papers (2015–2015)Thomas Butt · UK Dementia Research Institute1 papers (2015–2015)Ahmed B. Sallam · Advanced Research Projects Agency - Energy1 papers (2013–2013)Gerald Liew · Liverpool Hospital1 papers (2015–2015)